Thank you for submitting your manuscript for consideration by The EMBO Journal. It has now been seen by three referees whose comments to the authors are shown below. You will be pleased to see that the referees are generally very positive about your work and that they would support its ultimate publication in The EMBO Journal pending an appropriate revision. I would thus like to invite you to prepare a revised manuscript in which you need to address the referees' comments in an adequate manner. In particular, it would strengthen the study even further if you were able to generalise your findings along the lines suggested by referee 1.
I should remind you that it is EMBO Journal policy to allow a single round of revision only and that, therefore, acceptance of the manuscript will depend on the completeness of your responses included in the next, final version of the manuscript.
Thank you for the opportunity to consider your work for publication. I look forward to your revision.
Yours sincerely, Editor
The EMBO Journal
------------------------------------------------REFEREE REPORTS Referee #1 (Remarks to the Author):
This is an excellent piece of work. The data are of superb quality, the presentation extremely clear and well-written, and the interpretation of the results beyond reproach. I have no doubts that PPR10 binds the sequences delimited in these experiments, or that this binding defines the termini of the respective transcripts in maize chloroplasts. In a well-argued and thought-provoking discussion, the authors then go well beyond their own data to propose a general model for the maturation of polycistronic transcripts, bringing in observations from past work on plant organellar RNA maturation (their own, and that of other groups) and bacterial RNA maturation. This generalisation of their observations to explain much of what has appeared complicated and confused in previous work is laudable and in my view is what would justify publication in a prestigious journal with a wide readership such as EMBO Journal. However, I would prefer to see more data to support the broader implications that are discussed, so that the reader can gain a better insight into how general the phenomenon described here really is. For example, on p9 the manuscript suggests briefly that CRP1, another maize chloroplast PPR protein, acts in the same way on petB/petD transcripts. However, the original papers cited (from the same group) did not propose this mode of action. It would strengthen the generalisability of the manuscript if transcripts from wild-type and crp1 mutants were re-investigated in more detail with the hindsight afforded by the PPR10 results to verify the similarity. Similarly, on p12, it is implied that other overlapping transcripts have been observed in the past that would be coherent with the model described, but they are not listed or cited. The only example cited, as they admit, is of a polycistronic mRNA that is cleaved to give mature mRNAs that do not overlap (in fact, in the rps7/ndhB transcripts, there is a gap between the 3' end of the mature rps7 transcript and the 5' end of the ndhB trasncript). Considerable amounts of mapping data have been published on chloroplast RNAs from several species, and I would think it possible for the authors to do a more systematic job of surveying the literature for examples that fit or do not fit the model that is proposed. These could then be presented as a table, or as figures showing specific examples.
Minor points 1. Figure 7A and p8. Based on the behaviour on a size-exclusion column, the authors suggest PPR10 is a homo-dimer. However, this could instead indicate the protein has an unusually large Stokes' radius. If PPR proteins are rod-like, as predictions of their structure would suggest, they would mimic much larger proteins by this chromatography technique. I believe that proposing the protein is a dimer is premature without further evidence.
2. Figure 7C . Fifty-fold (atpH) or five hundred-fold (psaJ) excesses of protein were used at the lowest concentrations employed, and gave what looks like saturated binding. It would be informative to try lower ratios of protein to RNA until a dose-response curve appears. Also, traditionally, competitor experiments are used to demonstrate sequence-specific binding. What excess of cold atpH-b competitor, say, can compete out the atpH-a probe? Can psaJ-a compete out atpH-a or vice-versa? This could have relevance for regulation of gene expression if PPR10 is not in excess in vivo.
Referee #2 (Remarks to the Author):
A large number of nucleus-encoded factors are known to be required for specific post-transcriptional steps in chloroplast gene expression and play a key role in the coordination of the activities of the nuclear and chloroplast genomes. Many of these proteins belong to the PPR protein family. Although several of these proteins have been identified and studied, little is known on how they act mechanistically. In this manuscript the authors have thoroughly characterized a maize PPR protein called PPR10. They show that this protein is required for the stable accumulation of two sets of transcripts whose 5' or 3' ends map within two defined chloroplast regions from maize. In a series of technically demanding experiments, they demonstrate convincingly that PPR10 binds specifically to these two intergenic RNA regions. Moreover the PPR10 binding sites map within the short overlap of these transcripts derived by processing from precursor RNAs. These results are important as they reveal that PPR10 acts as a barrier to RNA decay from both 5' and 3' directions and could define in this way the termini of chloroplast transcripts. This work provides important new mechanistic insights into chloroplast RNA processing and stability, in particular on the processing of overlapping RNAs. Moreover the authors propose an attractive model for differential chloroplast RNA stability. This work should thus be of considerable interest to a wide readership.
Minor comments
The authors state that PPR10 defines the position of the 5' and 3' termini of certain RNAs. It would be interesting to test whether PPR10 can mimick this in vitro with precursor RNA and addition of 5' or 3' commercial exonucleases. This may however go beyond the scope of this manuscript. P.3, top Chloroplast chromosomes exist generally as linear concatemers with only a few circular molecules (see Oldenburg and Bendich, J. Mol. Biol. 335, 953-970 (2004) . Supplementary Fig. 6 Indicate top of the gradient Referee #3 (Remarks to the Author):
Chloroplast gene expression, especially in higher plants, involves polycistronic transcription units that give rise to complex patterns of mono-and oligo-cistronic overlapping RNAs through a series of processing steps. It is commonly believed that i) most processing events are mediated by sequence-specific endonucleases, the existence of which has been, up to now, only poorly supported by experimental data, ii) the 5'ends of transcripts are most often stabilised by gene-specific stability factors of nuclear origin while iii) stem-loops structures stabilise the 3'ends of transcripts. In this article the authors present the functional characterisation of a PPR protein, PPR10, whose absence causes photosynthesis deficiency. By RIP-chip experiments, they determine that this phenotype likely results from the specific reduction in the abundance of transcripts derived from two independent transcription units, comprising atpH and psaJ, respectively. They characterise the binding site of PPR10, a ~25 nt region share by the two transcription units, that correspond to the 3' and 5' overlapping ends of ttranscripts. Together these result demonstrate that PPR proteins are involved not only in the stabilisation of transcripts 5'ends, but also in the stable formation of 3' ends. The experiments presented are of high quality and soundly support the demonstration of the authors. The results obtained allow them to reinterpret some older data (for example the role of Crp1 in the maturation of petB-petD transcripts), strongly suggesting that the described mechanism is of general significance for chloroplast gene expression. Together with recent advances in RNA metabolism in prokaryotes, this new finding allowed the authors to present a revised model explaining the processing and stability of chloroplast mRNAs. This model appears highly stimulating, not only for people working in the field of organelle gene expression but more widely for all those interested in mRNA decay and metabolism. Considering the quality of the experiments presented, I have only a few minor comments on the manuscript. ï Fig. 1 : If antibodies are available, it would be nice to include a western blot against a ribosomal protein (because of a possible effect of the mutation on rpl33 expression) and against PsaJ. ï Fig. P . 7, l. 14-17. Although the unchanged abundance of precursor transcripts in the ppr10 mutant is generally true, it should be note that in fig. 5B , the abundance of the intermediate transcript 4 is increased in the first three panel of the figure. This increase is not seen in the other panels because of the counteracting decrease of the comigrating transcript 4. ï To help the reader, the authors could refer in the legend of supplementary figure 4 (l. 9) to the last panel of fig. 5A , where the strong reduction in atpA transcripts 3 and 6 is much evident. ï p.10, second section and supplementary fig. 6 : the authors may mention the strong deficiency in transcript with atpH as the first cistron (13, 15, 16) as a explanation for the reduction in AtpH translation (cf. the lack of translation of PetD in the crp1 mutant). In that case, the role of PPR10 in translation would mainly be in generating transcript with free atpH 5'UTR. ï p. 11, l. 3-8: Even if the crs1 mutant lacking AtpF expression exhibits a similar modest reduction in chloroplast translation, can the authors exclude a more specific defect resulting from the strong reduction in (translatable) rpl33 transcripts (with a free 5'UTR -6 and 11)? ï p. 14, 1st {section sign}. Although this hypothesis about the differential expression of atpH transcript relative to other transcripts encoding ATP synthase subunit is very much attractive, is it supported by experimental data? Lincomycin treatments leave the coding sequences, some of which do contain AU rich tracts, free of protecting ribosomes. These treatments destabilise some chloroplast transcripts to some extend, other transcripts are even protected and I would have expected, according to the proposed mechanism, a more drastic effect (Gray et al, (2003) We are submitting this revised manuscript entitled "Site-specific binding of a PPR protein defines and stabilizes 5' and 3' mRNA termini in chloroplasts" (EMBOJ-2009-70456) for your consideration. We have modified the text to address many of the reviewers' comments, and have explained every decision not to do this in our detailed response below. Most importantly, we added a new experiment to address the request of the editor: "In particular, it would strengthen the study even further if you were able to generalise your findings along the lines suggested by referee 1." Our new results provide further support that our model is generally applicable. Furthermore, we now discuss the fact that there is actually much more evidence for the overlapping RNA termini predicted by our model than for the adjacent termini predicted by the previous model. Finally, we now link our model to a previous report describing "small non-coding" RNAs in chloroplasts; we present strong evidence that one such small RNA is simply the in vivo footprint of RNA bound to its cognate PPR protein (HCF152), and we suggest that many of these small RNAs may represent PPR binding sites.
We feel that support for a general model of this nature is very strong, although some details (e.g. the identity of the endonucleases and the effects of ribosomes) remain to be worked out.
We hope that you will now find the paper suitable for publication in The EMBO Journal.
Response to Reviews Referee #1
Reviewer:... I would prefer to see more data to support the broader implications that are discussed, so that the reader can gain a better insight into how general the phenomenon described here really is. For example, on p9 the manuscript suggests briefly that CRP1 .... acts in the same way on petB/petD transcripts. .... It would strengthen the generalisability of the manuscript if transcripts from wild-type and crp1 mutants were re-investigated in more detail with the hindsight afforded by the PPR10 results to verify the similarity.
Response: Transcripts from the wild-type and crp1 mutants had already been investigated in this manner: there is a ~30 nt overlap between the 5' end of the processed petD RNA and the 3' end of the processed PetB (both of which fail to accumulate in crp1 mutants). In fact, it was this prior observation that sensitized us to the possibility that something similar might be going on with PPR10. These results were (and are) described in the Introduction and Discussion of this current manuscript. To further address the reviewer's request, we mapped the processed 5' and 3' ends between another pair of genes: psbH and petB. The accumulation of these processed termini depends on the PPR protein HCF152 (Meierhoff et al, 2003) . Our new results are shown as Supplementary Figure 8 , and support the view that HCF152 acts in the same way as PPR10: the 3' end of the processed psbH RNA is ~24 nt downstream of the 5' end of the processed petB RNA. Intriguingly, this overlap corresponds precisely to one of the "small non-coding RNAs" detected in tobacco chloroplasts by Lung et al, (NAR 2006) . We hypothesize that this small RNA is simply the minimal HCF152 footprint: i.e. this RNA segment is protected by HCF152 from degradation by both 5' and 3' exonucleases. In fact, the accumulation of small RNA segments corresponding to PPR binding sites is predicted by our model. Thus, many PPR binding sites may be represented as "small non-coding RNAs" in chloroplasts and mitochondria. Several sentences addressing this have been added to the Discussion.
Reviewer: ... it is implied that other overlapping transcripts have been observed in the past that would be coherent with the model described, but they are not listed or cited. ......Considerable amounts of mapping data have been published on chloroplast RNAs from several species, and I would think it possible for the authors to do a more systematic job of surveying the literature for examples that fit or do not fit the model that is proposed.
Response: One would think that many processed chloroplast transcript ends have been mapped precisely, but this isn't the case. Two of us (Pfalz and Barkan) independently scoured the literature, and neither of us found examples in which intercistronic 3' termini were mapped with sufficient resolution to unambiguously address our model. (Precisely mapped 5' ends are common, because they are easily mapped by primer extension.) All reports that we could find of 3' mapping used ribonuclease-protection assays, typically with large, uniformly-labelled probes and often with ribonuclease T1 (which cleaves only after G's). These assays give a general idea of the location of 3' ends, but the resolution required to differentiate between adjacent and overlapping ends is difficult to achieve in this way. In some cases, authors made assumptions about the precise position of processed 3' ends based on their expectation that they map adjacent to the corresponding processed 5' end. However, the resolution of the data were insufficient to demonstrate this. In fact, our new data for the psbH/petB termini provide strong evidence that these match our model, and that a previous report suggesting these termini to be adjacent (based on low resolution data) was incorrect. We do not wish to critique these experiments in our paper, so we will mention only the few instances in which we feel that the conclusions are well-supported: the CRP1-dependent petB/petD termini (already cited), the rps7/ndhB termini (already cited), and one additional example: the psaC/ndhD intergenic region (Hirose and Sugiura, 1997). This last data set is complex, but it appears likely that the most abundant processed RNA isoforms overlap. It should be noted that the example of NON-overlapping termini we cited in the original manuscript is probably not relevant, because those two termini are very far apart, and the results in that paper suggest they are products of completely unrelated processing events. Thus, we are not aware of even a single example of precisely mapped termini that support the "old" model for intercistronic RNA processing. In contrast, there are now four well-documented cases of overlapping termini, and these all correspond to genetically-predicted (or established) PPR binding sites.
Minor points
1. Figure 7A and p8. Based on the behaviour on a size-exclusion column, the authors suggest PPR10 is a homo-dimer. However, this could instead indicate the protein has an unusually large Stokes' radius. If PPR proteins are rod-like.... I believe that proposing the protein is a dimer is premature without further evidence.
Response: We agree that the data are consistent with a rod-like monomer. However, our analytical ultracentrifugation data suggest a dimer (although this experiment needs repeating). We feel that it isn't premature to "propose" that PPR10 is a dimer, and we used the word "suggesting" to reflect this uncertainty. We have now added the following phrase to make this ambiguity more obvious: "Preliminary analytical ultracentrifugation data support this possibility (data not shown), BUT WE CANNOT ELIMINATE THE POSSIBILITY THAT rPPR10 IS A HIGHLY ELONGATED MONOMER."
2. Figure 7C . My response to this comes in two parts:
(i) Our binding assays used conditions designed to measure Kd, according to the accepted strategy used by RNA/protein biochemists. Here is a quote taken from Gomila and Gehrke, "Biochemical approaches for characterizing RNA-protein complexes in preparation for high resolution structure analysis." In: Plant Virology Protocols (2008) . "A common error in determining the affinity of RNAñprotein complexes is to use RNA concentrations that are in excess of the dissociation constant. The analysis should be done using extremely low RNA concentrations, and in protein excess. Carey and Uhlenbeck (21, 43) discuss the thermodynamic basis. " Under conditions in which the RNA is well below the Kd, the binding reaction is driven by the concentration of protein, and the precise concentration of RNA doesn't influence the amount of complex formed. It is only under these conditions that Kd can be estimated as the protein concentration at which 50% of the RNA is bound. We have done additional titrations, and various other assays that pinpoint the minimal RNA segments required to bind PPR10 with high affinity, but there is no room in this paper to include those data. Nor, as the reviewer agrees, are these additional data necessary to support the conclusions made in this paper. Regarding in vivo, relevance: We don't know the concentrations of the protein and RNA in vivo; the in vivo milieu is so different in any case that it is difficult to extrapolate occupancy in vivo based on in vitro assays. However, our RNA coIP data show clearly that the majority of atpH RNAs with the PPR10 binding site are occupied by PPR10 in native extract.
(ii) Although it is traditional in the organelle field to use competition assays to demonstrate sequence-specific binding, we don't feel that this is the best way to demonstrate specificity. The interpretation of competition assays depends on the intactness and precise quantification of the competitor; these are parameters that cannot be "seen" in the actual experiment. This is a significant concern, especially when in vitro transcripts are used as competitors. In contrast, the precise concentration of the radiolabeled RNA in GMS assays performed with trace amounts of RNA does not influence the result because the reaction is driven only by protein concentration. Also, one can directly "see" the intactness of the radiolabeled RNA on the gel. We feel strongly that we have performed and interpreted our binding experiments in a rigorous fashion. Specificity is the ratio of affinity for a "specific" ligand in comparison to affinity for a "non-specific" ligand. Our data show that PPR10 has a MUCH higher affinity for the sites it associates with in vivo than for adjacent sequences of the same length. Thus, it has specificity for these sequences. Competition assays would show the same thing but in a more artifact-prone fashion. In fact, we suspect that some "specificity" conclusions reported based on competition data are incorrect. For example, we believe that the HCF152 binding site corresponds to the overlap we mapped between the psbH and petB RNA termini (which also matches the small noncoding RNA in tobacco), and NOT to the sequence inferred based on the results of competition assays (Nakamura et al, 2003) . We do not wish to critique this other work in our paper. There is no room in this paper to even refer to a supplemental figure with our additional RNA binding data. Furthermore, the reviewers agree that the results presented already are unequivocal with regard to support for a physiologically-relevant interaction between PPR10 and the sites we identify. We do not wish to remove any of the remaining text (all of which we feel is essential) in order to make room for these additional details, which we feel are not important for the central arguments we are making.
Reviewer: "The authors state that PPR10 defines the position of the 5' and 3' termini of certain RNAs. It would be interesting to test whether PPR10 can mimick this in vitro with precursor RNA and addition of 5' or 3' commercial exonucleases. This may however go beyond the scope of this manuscript."
Response: We agree, and experiments of this nature are in progress.
Reviewer: "P.3, top Chloroplast chromosomes exist generally as linear concatemers with only a few circular molecules (see Oldenburg and Bendich, J. Mol. Biol. 335, 953-970 (2004) ."
Response: Thank you for pointing this out. We have corrected this.
Reviewer: Supplementary Fig. 6 Indicate top of the gradient Response: done.
Referee #3 (Remarks to the Author):
Reviewer: If antibodies are available, it would be nice to include a western blot against a ribosomal protein (because of a possible effect of the mutation on rpl33 expression) and against PsaJ.
Response: We do not know of an antibody against PsaJ. We have western blot data for Rpl2, and we found that it accumulates to slightly reduced levels in ppr10 mutants. We chose not to show this because we suspect that there is preferential translation of ribosomal proteins under conditions of compromised translation (based on many observations with many mutants). Showing this data would require a discussion of these issues, which would detract from the central points we are making (which are not influenced by this). Furthermore, there is no room in the manuscript to discuss them, as we are up against the EMBO length limit. It should be noted that the overall level of rpl33 transcripts in ppr10 mutants is reduced only a very small amount, because the affected terminus is a minor one.
Reviewer:. Although the unchanged abundance of precursor transcripts in the ppr10 mutant is generally true, it should be note that in fig. 5B , the abundance of the intermediate transcript 4 is increased in the first three panel of the figure. This increase is not seen in the other panels because of the counteracting decrease of the comigrating transcript 4.
Response: We are confused by this comment. The first two panels use probes that don't hybridize to transcript 4. Panel 3 does show transcript 4-but its abundance looks similar in ppr10 and in the control hcf7 mutants.
Reviewer; To help the reader, the authors could refer in the legend of supplementary figure 4 (l. 9) to the last panel of fig. 5A , where the strong reduction in atpA transcripts 3 and 6 is much evident.
Response: Done.
Reviewer;: the authors may mention the strong deficiency in transcript with atpH as the first cistron (13, 15, 16) as a explanation for the reduction in AtpH translation. In that case, the role of PPR10 in translation would mainly be in generating transcript with free atpH 5'UTR.
Response: We added this possibility.
Reviewer: Even if the crs1 mutant lacking AtpF expression exhibits a similar modest reduction in chloroplast translation, can the authors exclude a more specific defect resulting from the strong reduction in (translatable) rpl33 transcripts?
Response: We consider this explanation to be very unlikely. The PPR10-dependent rpl33 RNA isoforms make only a tiny contribution to the overall population of rpl33 RNA. Also, this processed end is very far upstream of the rpl33 start codon. We consider it unlikely that processing so far upstream would dramatically influence translation or that this isoform is responsible for more than a small fraction of RPL33 synthesis. Unfortunately, there is no room in the text to discuss these issues (which are not germane to the main points of this paper).
Reviewer; Although this hypothesis about the differential expression of atpH transcript relative to other transcripts encoding ATP synthase subunit is very much attractive, is it supported by experimental data? Lincomycin treatments leave the coding sequences, some of which do contain AU rich tracts, free of protecting ribosomes. These treatments destabilise some chloroplast transcripts to some extend, other transcripts are even protected and I would have expected, according to the proposed mechanism, a more drastic effect (Gray et al, (2003) ...).
Response: We agree that our proposal concerning ribosomes on RNA stability in chloroplasts is speculative. However, we feel that it is a very reasonable working model in light of the following considerations.
(i) Recent reviews that address the effects of ribosomes on RNA turnover in bacteria discount studies that used antibiotics because of their secondary effects (see, for example, Deana and Belasco , Genes & Dev 2005, which is now cited in our paper). Antibiotics bind RNA, and so can influence RNA turnover in that way. Antibiotics in chloroplasts also block production of the PEP polymerase, which in turn influences the pattern of transcription. This in turn is known to have secondary effects on the accumulation of "NEP" transcripts in chloroplasts.
(ii) The cited study analyzed RNA after 5 days of lincomycin treatment. At this time, secondary effects (including potential compensating effects and an increase in NEP transcripts) are very likely. Nonetheless, it is intriguing that the vast majority of "photosynthesis gene transcripts" in the chloroplast do seem to be reduced by the lincomycin treatment; this seems, if anything, to support our model. However, too much stock should not be put into that one dataset because it appears the microarray experiment was performed just once, there is no statistical analysis of the data, only steady-state measurements were made, and antibiotics will have secondary effects in any case. Bound ribosomes must block access by stromal nucleases simply because there isn't room for a nuclease to gain access to the intimately-associated mRNA (thus, the 30 nt "footprint" observed when ribosomes bound to RNA are treated in vitro with ribonucleases). Whether this makes a significant contribution to defining the positions of the initial cleavages on chloroplast RNA remains to be seen. However, the consensus in the bacterial field is that translating ribosomes do reduce endonucleolytic attack, so it seems like a reasonable proposition to make for chloroplast RNAs. Again, this is just a working model, and these various issues need to be explored in future experiments.
2nd Editorial Decision 13 March 2009
Thank you for sending us your revised manuscript. Our original referee 1 has now seen it again. In general, he/she is now very positive about publication of your paper. Still, he/she has two minor suggestions (see below). First he/she feels that the discrepancy to Nakamura et al. should be pointed out in some way in the main body of the text. Second, he/she feels that it would be a good thing if some of the replies in your point-by-point could be included into the main body of the text. I was wondering whether you would like to consider addressing these minor issues suggested by referee 1, and I would like to add that it would not be a problem to extend the length of the manuscript to incorporate these extra points. Your present manuscript text is well below of length restriction of 55,000 characters including spaces, excluding references (presently about 45,500).
Furthermore, there is one remaining editorial issue that needs further attention. Prior to acceptance of every paper we perform a final check for figures containing lanes of gels that are assembled from cropped lanes. While cropping and pasting may be considered acceptable practices in some cases (please see Rossner and Yamada, JCB 166, 11-15, 2004 ) there needs to be a proper indication in all cases where such processing has been performed according to our editorial policies. Please note that it is our standard procedure when images appear like they have been pasted together without proper indication (like a white space or a black line between) to ask for the original scans (for our records).
In the case of the present submission there are a number of panels that appear to not fully meet these requirements: Figure 5 A, and B, Supplementary figure 5, bottom row last panel.
I therefore like to kindly ask you to send us a new version of the manuscript that contains suitably amended versions of these figures. I feel that it would also be important to explain the assembly procedure for these figures in the figure legend (i.e. that all lanes come from the same gel). Please be reminded that according to our editorial policies we also need to see the original scans for the figures in question. I would also like to encourage you to check all the other panels along these lines. I am sorry to have to be insistent on this at this late stage. However, we feel that it is in your as well as in the interest of our readers to present high quality figures in the final print version of the paper.
Please let us have a suitably amended manuscript as soon as possible. Thank you very much for your cooperation.
Yours sincerely,
Editor
The EMBO Journal ___________________________________ REFEREE REPORTS Referee #1 (Remarks to the Author):
CRP1
I apologise if I gave the authors the impression that I had not read their manuscript; I should have been more explicit in my previous review. Barkan et al (1994) reported a c. 30nt overlap between petB and petD transcripts, mapped by RNase protection and S1 nuclease protection, neither of which give as accurate or definitive results as the cRT-PCR used in this study. More importantly, the region containing this 30nt sequence was not found to be bound by CRP1 in Schmitz-Linneweber et al (2005) and as far as I can see, there is no sequence similarity between the sequences that were found to be sites bound by CRP1 and the petB/petD overlap. Hence the current published data are much less clear than those presented here for PPR10, and I would have liked to have seen more experimental data to add weight to the idea that CRP1 does indeed bind in the petB/petD intercistronic region, acting as demonstrated here for PPR10. However, the new data on the psbH/petB transcripts (see below) satisfy me that the phenomenon they describe is sufficiently common to be presented as a general mechanism.
HCF152
The new data are interesting and support the authors' hypothesis. I think they strengthen the paper considerably. However, as they note in their reply to the reviewers, there is some discrepancy between the overlap found between the psbH and petB transcripts and the sequences reported to be HCF152 binding sites by Nakamura et al. Although I understand the reluctance of the authors to be seen as possibly throwing doubt on other researchers' work, I think that this discrepancy should be pointed out such that readers are aware that it exists, and can then make their own judgement. [For example by extending the new paragraph that they have added on p13: "...it seems likely that this small non-coding RNA is actually the in vivo HCF152 footprint, although it does not exactly correspond to any of the binding sites proposed on the basis of in vitro cross-linking experiments (Nakamura et al., 2003) ."] Termini mapping I thank the authors for their efforts to find other examples in the literature, and hope they will excuse me for overestimating the likelihood of finding any. Nonetheless, I think the paragraph added on p12 strengthens the paper by leaving less doubt in readers' minds that something has been overlooked.
I am happy with all the other modifications that have been made, and I appreciate the thoughtful and detailed replies made to the reviewers' comments. It is a shame that length restrictions preclude some of these explanations being added to the text! I reiterate that this an excellent piece of work of wide general interest. Revised manuscript: EMBOJ-2009-70456 We are submitting this revised manuscript entitled "Site-specific binding of a PPR protein defines and stabilizes 5' and 3' mRNA termini in chloroplasts" (EMBOJ-2009-70456) for your consideration. We amended the text concerning the HCF152 binding site as suggested by the reviewer, and we expanded the Discussion to flesh out some ideas more thoroughly. We also added lines to the panels in Figures 5 and Supplementary Figure 5 , as requested by the editor, to indicate where lanes had been cropped out. Those figure legends were modified to state that all lanes in each panel came from the same gel. The original scans for all of those gels have been uploaded as well. We hope that you will now find the paper suitable for publication in The EMBO Journal.
